13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groupsTools Daniel, Priya and Rodrigo, Chamira and Bewick, Thomas and Sheppard, Carmen and Greenwood, Sonia and McKeever, Tricia M. and Trotter, Caroline and Lim, Wei Shen (2018) 13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups. Vaccine, 36 (12). pp. 1614-1620. ISSN 0264-410X
AbstractThere is debate regarding the value of vaccinating adults with the 13-valent pneumococcal conjugate vaccine (PCV-13). This analysis was conducted to investigate the risk of PCV-13 serotype community acquired pneumonia (CAP) in hospitalised adults with co-morbid disease and risk factors for pneumococcal disease in the UK.
Actions (Archive Staff Only)
|